Sample Mining and Data Mining: Combined Real-Time and Retrospective Approaches for the Identification of Emerging Novel Psychoactive Substances

Novel psychoactive substances (NPS) are synthetic drugs that pose serious public health and safety concerns. A multitude of NPS have been identified in the United States, often implicated in forensic investigations. The most common and effective manner for identifying NPS is by use of mass spectrometry and the true utility lies within nontargeted acquisition techniques. During this study, a liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) assay was developed, validated, and implemented for forensic toxicology testing. A SCIEX TripleTOF™ 5600 + with SWATH^® acquisition was used. Resulting data were compared against an extensive library database containing more than 800 compounds. The LC-QTOF-MS assay was applied to the reanalysis of biological sample extracts to discover emergent NPS. More than 3,000 sample extracts were analyzed, and more than 20 emerging NPS were detected for the first time. Among these were isopropyl-U-47700, 3,4-methylenedioxy-U-47700, fluorofuranylfentanyl, N-methyl norfentanyl, 2F-deschloroketamine, 3,4-methylenedioxy-alpha-PHP, eutylone, and N-ethyl hexedrone.     

High performance liquid chromatographic determination of alcohols with reference to body distribution of methanol

A method has been developed on reverse phase high performance liquid chromatography for simultaneous determination of methyl, ethyl and isopropyl alcohols under refractive index detection using pure water as the mobile phase. A good separation has been achieved between these alcohols. Detector response was linear with a detection limit of 5 mg/100 ml. Recovery studies were performed by adding known amounts of methyl and ethyl alcohols to blood, lung and liver within the range 80–90%. The reproducibility of the results was always >90%. The quantitative distribution of methyl alcohol in postmortem body tissues and fluids has been reported in three cases of poisoning.     

DNA commission of the International Society of Forensic Genetics: Recommendations on the interpretation of mixtures

The DNA commission of the International Society of Forensic Genetics (ISFG) was convened at the 21st congress of the International Society for Forensic Genetics held between 13 and 17 September in the Azores, Portugal. The purpose of the group was to agree on guidelines to encourage best practice that can be universally applied to assist with mixture interpretation. In addition the commission was tasked to provide guidance on low copy number (LCN) reporting. Our discussions have highlighted a significant need for continuing education and research into this area. We have attempted to present a consensus from experts but to be practical we do not claim to have conveyed a clear vision in every respect in this difficult subject. For this reason, we propose to allow a period of time for feedback and reflection by the scientific community. Then the DNA commission will meet again to consider further recommendations.     

论规制市场监管者应遵循的法律原则

按照权力分工或者权力划分理论,政府作为国家管理社会文化经济事务的公共代表,管理具有公共性社会事务,这是无庸置疑的。在我国政府管理与规范市场的活动中,就市场资格、市场运行、市场秩序、市场走向以及特定的市场交易行为过程而言,无论是专业市场还是一般交易市场,监管者的权力可以说是无所不在;但是,当监管者行使监管权力偏离法律的正当预期时,对监管者的规制就成为一项不可或缺而且艰巨的任务。     

Acidic and neutral drugs screen in blood with quantitation using microbore high-performance liquid chromatography–diode array detection and capillary gas chromatography–flame ionization detection

Blood previously acidified with aqueous saturated ammonium chloride solution was extracted with ethyl acetate. The dried extract was subjected to acetonitrile–hexane partition. The acetonitrile portion was analysed for the presence of acidic and neutral drugs by HPLC–DAD (200 mm×2.1 mm I.D. microbore ODS-Hypersil column) and GC–FID (25 m narrow-bore×0.25 mm I.D. HP-5 column with 0.33 μm film thickness). The protocol was found to be suitable for both clinical toxicology (including emergency toxicology) and postmortem toxicology. At least 66 drugs of interest were unequivocally identified by RRTs (HPLC) and UV spectra (DAD) match while another 12 were unequivocally identified by double RRTs match (HPLC and GC). Quantitation was facilitated by incorporating calibration blood standards in each assay batch. The five drugs most commonly encountered in clinical blood specimens (1150 cases) were: paracetamol (47.4% of the cases); chlormezanone (6.6%), theophylline (1.74%), naproxen (1.65%) and mefenamic acid (1.56%). The following drugs were detected in toxicologically significant quantities in postmortem blood specimens (245 cases): phenobarbitone (1.22% of the cases), naproxen (0.82%), chlormezanone (0.82%), theophylline (0.82%), carbamazepine (0.41%) and paracetamol (0.41%).     

绵羊血浆阿维菌素荧光高效液相色谱检测法的建立

建立了一种绵羊血浆中阿维菌素 (AVM )荧光高效液相色谱 (HPLC)检测法。用甲醇提取绵羊血浆中的AVM ,并用ODS C18固相萃取法进行纯化 ,纯化后的AVM经干燥处理后 ,用三氟乙酸酐和N 甲基咪唑对其进行荧光衍生化 ,用荧光HPLC进行检测。本方法的最低检测限为 0 .1ng/mL ,在血浆AVM含量 2 .5～ 5 0 .0ng/mL范围内 ,标准曲线方程为Y =2 72 12x -10 412 (r =0 .9995 ) ,样品的平均回收率为 92 .0 2 %± 6.3 3 %。批内变异系数 1.98%～ 6.2 2 % ,批间变异系数 2 .3 1%～ 8.94%。检测结果显示 ,本方法灵敏度高 ,干扰少 ,重复性好。     

K~+/Na~+比值与损伤时间的关系

本文使用原子吸收光谱法测定12只大鼠36个烧伤局部肌肉标本的 K~+/Na~+值,检测结果:生前60、 30、 15min 以及死后20min 肌肉标本的 K~+/Na~+值比对照组分别下降:69～94％(平均86％)、56～89％(平均77％)、47～82％(平均71％)、4～38％(平均27％),此结果经统计学处理,表明生前伤与死后伤的 K~+/Na~+比值的下降率有明显差异。同时发现生前损伤的各实验组随存活时间的延长,K~+/Na 比值的下降率有增加的倾向。笔者认为,此方法是烧伤时间推断的一种简便,可靠的方法,对法医学实践有一定实用价值。     

8例利多卡因过敏性休克死的血药浓度分析

目的研究利多卡因过敏性休克死者利多卡因血药浓度及其与死因的关系。方法采用高效液相色谱法(HPLC),分别对使用利多卡因麻醉术中各项指标均正常的8例术中因利多卡因过敏性休克死者的血液和11例顺利完成手术患者的血液进行利多卡因浓度的检测,对比分析两者结果。结果 8例死者利多卡因血药浓度(1．61mg± 0．45mg／L)低于11例正常患者利多卡因血药浓度(2．44mg±0．47mg／L)。结论利多卡因过敏性休克死者血药浓度在正常值范围内,与发生过敏性休克致死无关。     

UPLC分析大鼠血浆中阿齐沙坦浓度及其初步药代动力学研究

目的 采用UPLC建立大鼠血浆中阿齐沙坦浓度的测定方法,并探究阿齐沙坦在大鼠血浆中初步药代动力学情况。方法 选用缬沙坦为内标,色谱柱Kinetex C18（100 mm×2.10 mm,1.7 μm）,紫外检测波长254 nm,流动相为水-乙腈-冰醋酸（容积比为57∶42∶1）,流速0.2 mL/min,柱温25 ℃,进样量2 μL,建立在大鼠血浆中阿齐沙坦的分析方法。在此方法的基础上,经大鼠尾部静脉注射阿齐沙坦0.5 mg/kg,测定不同时间点其血浆浓度。实验数据运用DAS 2.1软件分析,得其主要药代动力学参数。结果 大鼠血浆中阿齐沙坦的线性范围为0.05～12.5 mg/L（r=0.999 9）,定量下限为0.05 mg/L,低、中、高浓度（0.1、1.0、10.0 mg/L）的提取回收率分别为（88.6±3.2）%、（86.5±2.2）%、（85.7±1.3）%（RSD<5%）,日内、日间精密度RSD不大于10%,准确度在85%~100%范围内。通过DAS 2.1软件拟合,阿齐沙坦的分布半衰期t1/2（α）为（0.39±0.04）h,消除半衰期t1/2（β）为（4.22±0.12）h,药时曲线下面积（AUC0-t）为每小时（53.25±2.46）mg/L。结论 本实验建立的UPLC操作快速、简单,且专属性强,适用于阿齐沙坦在大鼠血浆中浓度的分析及其药代动力学的探究。     

酮洛芬注射液在乳牛体内的残留消除研究

为建立牛乳中酮洛芬的液相色谱-串联质谱(LC-MS/MS)检测方法,牛乳样品经甲醇提取,C18色谱柱分离,采用正离子模式,多反应监测,内标法定量。结果表明,牛乳中酮洛芬的检出限为1μg/kg,定量限为5μg/kg,在5~200μg/kg范围内线性关系良好,相关系数大于0.99。在25~100μg/kg添加水平的回收率为93.3%~107.5%,批内、批间相对标准偏差分别为1.72%~5.46%、1.13%~7.04%。该方法高效、灵敏、准确,可作为牛乳中酮洛芬的检测方法。选用20头健康的泌乳期荷斯坦乳牛,高产、低产各10头,以3 mg/kg剂量肌内注射给药,每天1次,连用3 d,分别于每次给药后第2、15小时采集乳样。每次给药后2 h牛乳中可检出酮洛芬,最高质量分数为(38.43±3.90)μg/kg,停药后15 h均未检出。所有时间点牛乳中酮洛芬质量分数的实测结果均低于加拿大规定的最高残留限量50μg/kg,建议弃乳期为0 d。